New directions in lung cancer: Chemoprevention

Seminars in Respiratory and Critical Care Medicine

Volumn 17, Issue 4, 1996, Pages 323-334

  Khuri, Fadlo R ^a   Hong, Waun Ki ^a   Lee, Jin Soo ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHUS MUCOSA; CANCER PREVENTION; CANCER RISK; CHEMICAL CARCINOGENESIS; HUMAN; LUNG CANCER; PRIORITY JOURNAL; REVIEW; SMOKING;

EID: 8944241301     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1009904     Document Type: Review

References (84)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics, 1996. CA Cancer J Clin 1996;46:5-27
2. Ginsberg RJ, Kris MG, Armstrong JG. Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 4th ed. Lippincott, Philadelphia 1994;673-722
3. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1976;68:820-4
4. Strong MS, Incze J, Vaughan CW. Field cancerization in the aerodigestive tract - its etiology, manifestation, and significance. J Otolaryngol 1984;13:13-6
5. Kraemer KH, DiGiovanna JJ, Moshell AN, et al. Prevention of skin cancer in xeroderma pigmanterum: the use of isotretinoin. N Engl J Med 1988;318:1633-7
6. Slaugher DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:963-8
7. Garner RC, Cuzick J, Jenkins D, et al. Linear relationship between DNA adducts in human lung and cigarette smoking. IARC Sci Publ 1990;104:421-6
8. Phillips DH, Schoket B, Hewer A, et al Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells Int J Cancer 1990;46: 569-75
9. Phillips DH, Hewer A, Martin CN, et al Correlation of DNA adduct levels in human lung with cigarette smoking. Nature 1988;336:790-2
10. Stich HF. Micronucleated exfoliated cells as indicator for genotoxic damage and as markers in chemoprevention trials. J Nutr Growth Cancer 1987;4:9-18
11. Benner SE, Lippman SM, Wargovich MJ, et al. Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis. IntJ Cancer 1992;52:44-7
12. Voravud N, Shin DM, Ro JY, et al. Increased polysomies of chromosome 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 1993;53:2874-83
13. Oschsner A, DeBakey M. Carcinoma of the lung. Arch Surg 1941;42:209-58
14. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma: a study of six hundred and eighty-four proved cases. JAMA 1950;143:329-36
15. Doll R, Hill AB. Smoking and carcinoma of the lung: preliminary report. Br Med J 1950;2:739-48
16. Lee JS, Hong WK. Biology of preneoplastic lesions. In Roth JA, Cox JD, Hong WK, eds. Lung Cancer. Blackwell Scientific Publications, Boston 1993:34-56
17. Auerbach O, Stout AP, Hammond EC, et al. Changes in bronchial epithelium in relation to lung cancer. N Engl J Med 1961;265:253-67
18. Trichopoulus D. Mollo F, Tomatis L, et al. Active and passive smoking and pathological indicators of lung cancer risk in an autopsy series. JAMA 1992;268:1697-1701
19. Inman DS, Harris CC. Oncogenes and tumor suppressor genes in human lung carcinogenesis. Crit Rev Oncog 1991; 2:161-71
20. Ihde DC, MinnaJD. Non-small cell lung cancer. Part I. Biology, diagnosis, and staging. Curr Probl Cancer 1991;15:61-104
21. Lee JS, Pathak S, Hopwood V, et al. Involvement of chromosome 7 in primary lung tumors and nonmalignant normal lung tissue. Cancer Res 1987;47:6349-52
22. Miura I, Siegfried JM, Resau J, et al. Chromosome alterations in 21 non-small cell lung carcinomas. Genes Chromosomes Cancer 1990;2:328-38
23. Sozzi G, Miozzo M, Tagliabue E, et al. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res 1991;51:400-4
24. Hittelman WN, Wang ZW, Cheong N, et al. Premature chromosome condensation and cytogenetics of human solid tumors. Cancer Bull 1989;41:298-305
25. Sohn HY, Cheong N, Wang ZW, et al. Detection of aneuploidy in normal lung tissue adjacent to lung tumor by premature chromosome condensation. Cancer Genet Cytogenet 1989; 41:250
26. Hittelman WN, Cheong N, Sohn HY, et al. Tumorigenesis and tumor response: view from the (prematurely condensed) chromosome. In: Obe G, Natarajan AT, eds. Chromosomal Aberrations: Basic and Applied Aspects (Advances in Mutagenesis Research). Springer-Verlag, Berlin 1990; 101-12
27. Kim SY, Lee JS, Ro JY, et al. Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in-situ hybridization: Mapping genotype/phenotype heterogenicity. Am J Pathol 1993;142:307-17
28. Lee JS, Kim SY, Hong WK, et al. Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. J Natl Cancer Inst 1993;85:1951-4
29. Gazdar AF, Hung J, Walker L, et al. Extensive areas of dysplasia and aneuploidy of the entire bronchial mucosal tract accompanies non-small cell lung cancers (NSCLC) and provides evidence for the field cancerization theory. Proc Am Soc Clin Oncol 1993;12:334
30. Kim HJ, Lee JS, Shin DM, et al. Chromosomal instability, p53 expression and retinoid response in oral premalignancy. (Abstract ) Proc Am Soc Clin Oncol 1995;14:81
31. Chung KY, Mukhopadhyay T, Kim J, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993;53:1676-83
32. Hung J, Kishimoto Y. Sujio K, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995;273:558-63
33. Sozzi G, Miozzo M, Donghi R, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 1992;52:6079-82
34. Christensen P, Joergensen K, Munk J, et al. Hyperfrequency of pulmonary cancer in a population of 415 patients treated for laryngeal cancer. Laryngoscope 1987;97:612-4
35. Shields TW, Humphrey EW, Higgins GA, et al. Long term survivors after resection of lung carcinoma. J Thorac Cardiovasc Surg 1978;76:439-42
36. Van Bodegon PC, Wagenaar SS, Corrin B, et al. Second primary lung cancer: Importance of long term follow-up. Thorax 1989;44:788-93
37. Thomas P, Rubinstein L, The Lung Cancer Study Group. Cancer recurrence after resection: T1N0 non-small cell lung cancer. Ann Thorac Surg 1990;49:242-7
38. Thomas PA, Rubinstein L, The Lung Cancer Study Group. Late appearance of malignancies after surgery for T1N0 non-small cell lung cancer. Lung Cancer 1991;7(Supp)):82
39. Smith RA, Nigan BK, Thompson JM. Second primary lung carcinoma. Thorac 1976;31:507-16
40. Craig J, Powell B, Muss HB, et al. Second primary bronchogenic carcinomas after small cell carcinoma: Report of two cases and review of the literature. Am J Med 1984;176: 1013-20
41. Johnson BE, Ihde DC, Matthews MI, et al. Non-small cell lung cancer: major cause of late mortality in patients with small cell lung cancer. Am J Med 1986;80:1103-10
42. Heyne KH, Lippman SM, Lee JS, et al. The incidence of second primary tumors in long-term survivors of small cell lung cancer. J Clin Oncol 1992;10:1519-24
43. Osterlind K, Hanga HH, Hanga M, et al. Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small cell lung cancer. J Clin Oncol 1986;4:1044-52
44. Hong WK, Lippman SM, Itri LM, et al. Prevention of secondary primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801
45. Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-22
46. Willet WM, McMahon B. Diet and cancer: an overview. N Engl J Med 1984;310:633-8
47. Ziegler RG, Sund AF, Craft NE, et al. Does β-carotene explain why reduced cancer risk is associated with vegetable and fruit intake? Cancer Res 1992;52(Suppl):2060S-2066S
48. Boone CW, Kelloff GJ, Malone WE. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res 1990;50:2-9
49. Kelloff J, Boone CW, Malone WI. Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute. In: Wattenburg L, Lipkin M, Boone CW, Kelloff GJ, eds. Cancer Chemoprevention. CRC Press, Boca Raton, FL 1992;41-56
50. Sporn MB, Dulop NM, Newton DL, et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976;35:1332-8
51. Peto R, Doll R, BuckleyJD, Sporn MB. Can dietary β-carotene materially reduce human cancer rates? Nature 1981;290: 201-8
52. De Luca LM. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEBJ 1991;5:2924-33
53. Hong WK, EndicottJ, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315: 1501-5
54. Besa EC, Abrams JL, Nowell PC. Comparison of efficacy and toxicity of 13-cis-retinoic acid (RA) with or without alpha-tocopherol in myelodysplasia. Proc Am Soc Hem 1987;70:222a
55. Warrell RP, Frankel SR, Miller WH, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991;324:1385-93
56. Lippman SM, Kavanagh J, Paredes-Espinoza M, et al. 13-cis-retinoic acid plus interferon alpha2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1992;84:241-5
57. Lippman SM, Parkinson D, Itri L, et al. 13-cis-retinoic acid plus interferon alpha 2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992;84:235-41
58. Lotan R, Sozzi G, Ro J, et al. Selective suppression of retinoic acid receptor β(RAR β) expression in squamous metaplasia, and in non-small cell lung cancer (NSCLC) compared to normal bronchial epithelium. (Abstract) Proc Am Soc Clin Oncol 1995;14:165
59. Menkes MS, Constock GW, Vuilleumier JP, et al. Serum β-carotene, vitamins A and E, selenium and the risk of lung cancer. N EnglJ Med 1986;315:1250-4
60. Heimburger DC, Krumdieck CL, Alexander CB, et al. Localized folie acid deficiency and bronchial metaplasia in smokers: hypothesis and preliminary report. Nutr Int 1987;2:54-60
61. Heimburger DC, Alexander CB, Burch R, et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 1988;259:1525-30
62. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 1993;85:457-64
63. U.S. Department of Health and Human Services. Strategies to control tobacco use in the United States: a blueprint of public health action in the 1990s. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. NIH Publ. No. 92-3316, 1991.
64. Strauss G, Gleason R, Cato J, Sugarbaker D. Screening for lung cancer: another look, a different view. Proc Seventh World Conference on Lung Cancer, Colorado Springs, 1994.
65. Spitz M. (personal communication)
66. Benner SE, Pajak TF, Lippman SM, et al. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst 1994;86:140-41
67. Bolla M, Lafir R, Tom Van J, et al. Prevention of second primary tumors with etretinate in squamous cell carcinoma of the oral cavity and oropharynx: results of a multicentric double-blind randomized study. EurJ Cancer 1994;30:727-9
68. Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta-carotene to prevent oral carcinogenesis. N Engl J Med 1993;328:15-20
69. Hong WK (unpublished data)
70. Such HF, Hornby AP, Mathew B, et al. Response of oral leukoplakia to the administration of vitamin A. Cancer Lett 1988;40:93-101
71. Chiesa F, Tradati N, Marazzo M, et al. Prevention of local relapses and new localization of oral leukoplakias with the synthetic retinoid Fenretinide (4-HPR). Preliminary Results. Oral Oncology, EurJ Cancer 1992;28:97-102
72. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effects of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35
73. Stampfer MJ, Willet WE, Hennekens Ch. Choice of populations for cancer prevention trials, In Moon TE, Micozzi MS, eds. Nutrition and Cancer Prevention: Investigating the Role of Micronutrients. Marcel Dekker, New York, 1989;473-82
74. McLarty J. Results of the Tyler chemoprevention trial: an intermediate endpoint study. Proc Sec Intl Conference Antioxidant Vitamins and Beta-Carotene. Disease Prev. 1994
75. Saccomanno G, Archer VE, Auerbach O, et al. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974;33:256-70
76. Saccomanno G, Moran PG, Schmidt RD, et al. Effect of 13-cis retinoic acid on premalignant and malignant cells of lung origin. Acta Cytol 1982;26:78-85
77. Arnold AM, Brownman GP, Levine MN. et al The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomized trial. BrJ Cancer 1992;65:737-43
78. Mathe G, Gouveia J, Hercend TM, et al. Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment. Cancer Detect Prev 1982;5:461-6
79. Lee JS, Lippman SM, Benner SE, et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 1994;12.937-45
80. Lippman SM. (personal communication)
81. Pastorino U, van Zandwijk N, de Vries N, et al. Results of Euroscan trial. Lung Cancer 1994;11:94-5
82. Dimery IW, Shirinian M, Heyne K, et al. Reduction in toxicity of high dose 13-cis retinoic acid (13cRA) with alpha-tocopherol (AT). (Abstract) Proc Am Soc Clin Oncol 1992;11:145
83. Lam S, MacAulay C, Hung J, et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Sur 1993;105:1035-40
84. Lee JS, Hong WK. Biology of preneoplastic lesions. In: Roth JA, Cox JD, Hong WK, eds. Lung Cancer. Blackwell Scientific, Cambridge, MA, 1993;34-56